ISR News 2.40 Isoray Inc (ISR)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Isoray Inc (ISR) 2.40 $ISR

IsoRay (ISR) Trips After Strong Monday Run
at The Street - Tue Apr 08, 12:54PM CDT
IsoRay (ISR) is slipping after a strong run-up on Monday on positive trial news.

Why IsoRay (ISR) Stock Is Up Today
at The Street - Mon Apr 07, 12:26PM CDT
IsoRay (ISR) climbed on Monday after the medical technology company announced a new human prostate implant to help treat prostate cancer. IsoRay unveiled the world's first human prostate cancer implant using its Cesium-131 seeds and C4 Imaging's...

IsoRay Announces World's First Human Prostate Implant Utilizing Cesium-131 Seeds and C4 Imaging's Positive Signal MRI Markers
Marketwire - Mon Apr 07, 8:03AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the first prostate cancer implant combining IsoRay's Cesium-131 seeds with C4 Imaging's Sirius(R) positive signal MRI markers.

Data Review on Active Stocks -- Research on Procter & Gamble, Halozyme Therapeutics, Symantec, and IsoRay
PR Newswire - Mon Apr 07, 7:25AM CDT
The trading session on Friday, April 04, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,412.71, down 0.96% and the NASDAQ Composite closed at 4,127.73, down 2.60%. The S&P 500 finished the session 1.25% lower at 1,865.09. The losses were broad based as nine out of ten sectors posted losses. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include The Procter & Gamble Co. (NYSE: PG), Halozyme Therapeutics Inc. (NASDAQ: HALO), Symantec Corp. (NASDAQ: SYMC) and IsoRay Inc. (NYSE MKT: ISR). Free technical research on PG, HALO, SYMC and ISR can be downloaded upon signing up at:

Biotech Stock Mailbag: Celgene, IsoRay, Northwest Bio, Bubble Worries
at The Street - Fri Apr 04, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

IsoRay (ISR) Builds on Conference Momentum
at The Street - Thu Apr 03, 12:36PM CDT
IsoRay (ISR) is rallying for its third consecutive day as positive sentiment surrounding the company's participation in a major medical conference gains momentum.

Hot Stock: IsoRay, Shares Gain 22.3% (ISR)
Comtex SmarTrend(R) - Tue Apr 01, 10:10AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 22.3% to $2.69 on 1.4x average daily volume. IsoRay has traded 16.0 million shares thus far today, vs. average volume of 11.1 million shares per day. The stock has outperformed the Dow (22.3% to the Dow's 0.4%) and outperformed the S&P 500 (22.3% to the S&P's 0.4%) during today's trading.

IsoRay (ISR) Rallies Ahead of Major Conference
at The Street - Tue Apr 01, 9:55AM CDT
IsoRay (ISR) is rallying on Tuesday ahead of its participation in a major medical conference toward the end of the week.

IsoRay Announces Five Presentations at the American Brachytherapy Society (ABS) Convention Reporting on the Ongoing Success of Cesium-131 in Fighting Cancer
Marketwire - Tue Apr 01, 7:46AM CDT
IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth (#301) at the Annual Meeting of the American Brachytherapy Society (ABS). The annual ABS meeting will take place April 3-5, 2014 in San Diego, California at the Manchester Grand Hyatt.

IsoRay, Inc. Closes $14,675,180 Registered Direct Offering
Marketwire - Thu Mar 27, 7:16AM CDT
IsoRay, Inc. (NYSE MKT: ISR) announced today that it closed on a $14,675,180 registered direct placement (the "Offering" of 5,644,300 shares of common stock at a price of $2.60 per share with two institutional investors yesterday. IsoRay intends to use the net proceeds from the Offering, estimated at approximately $13,821,421 after deducting the placement agent fees and estimated offering expenses, for working capital and general corporate purposes.

International Game Technology Cuts Previously Issued Guidance
ACCESSWIRE - Thu Mar 27, 4:05AM CDT
International Game Technology (NYSE: IGT) - For an in-depth report on International Game Technology follow: www.BullTrends.com/stockquote/IGT

Stock to Watch: IsoRay Up 20.4% (ISR)
Comtex SmarTrend(R) - Wed Mar 26, 10:11AM CDT
IsoRay (AMEX:ISR) is one of today's best performing low-priced stocks, up 20.4% to $2.48 on 1.1x average daily volume. IsoRay has traded 10.1 million shares thus far today, vs. average volume of 9.4 million shares per day. The stock has outperformed the Dow (20.4% to the Dow's 0.1%) and outperformed the S&P 500 (20.4% to the S&P's 0.1%) during today's trading.

IsoRay (ISR) Stock Rebounds After Last Week's Losses
at The Street - Wed Mar 26, 9:57AM CDT
IsoRay (ISR) recovered some of its losses from Friday, when the company priced its registered direct offering of common stock. The stock had surged more than 17% to a high of $2.52 as of 10:47 a.m. on Wednesday. The company announced last week it had...

IsoRay (ISR) Continues Fall on Heavy Volume
at The Street - Mon Mar 24, 12:46PM CDT
IsoRay (ISR) is continuing to drop on Monday after rallying in the middle of last week.

IsoRay (ISR) Is Today's Dead Cat Bounce Stock
at The Street - Mon Mar 24, 8:46AM CDT
Trade-Ideas LLC identified IsoRay (ISR) as a "dead cat bounce" (down big yesterday but up big today) candidate

IsoRay plans to offer common stock at USD2.60 per share
M2 - Mon Mar 24, 5:15AM CDT
Brachytherapy seeds company IsoRay (NYSE MKT:ISR) revealed on Friday that it intends to sell 5,644,300 shares of its common stock to two institutional investors.

Why IsoRay (ISR) Is Plunging Today
at The Street - Fri Mar 21, 9:02AM CDT
IsoRay (ISR) plunged on Friday after the company priced its registered direct offering of common stock. The company announced it had reached agreements with two institutional investors to sell 5,644,300 shares at $2.60 a share, which should yield...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immutable Expands Web3 Gaming Influence in Major Conference

Updated Category News Views 257

Immutable's Growing Presence at GDC 2025 Immutable is affirmatively stepping into the spotlight at the upcoming Game Developers Conference (GDC) 2025, a pivotal event that congregates the brightest minds of the gaming industry. With collaborations alongside notable partners such as RavenQuest, Polygon Labs, Sequence, and MetaGravity, Immutable is ready to showcase its...

Continue Reading
Rathbones Group's Influence on Empiric Student Property Plc

Updated Category News Views 239

Understanding Public Opening Position Disclosures Public opening position disclosures are essential for maintaining transparency in financial markets. This process is especially important for stakeholders interested in relevant securities, particularly when holdings exceed 1%. Disclosures must provide critical information on who owns shares and any short positions related...

Continue Reading
Rapid Nexus Achieves Historic Milestone in Wound Care Technology

Updated Category News Views 389

Rapid Nexus Receives FDA Clearance for Hemastyl Gel The FDA 510(k) clearance for its Hemastyl gel device marks the first technology that has treated the tissue surrounding chronic wounds and prevented numerous amputations. On a significant day in the realm of wound care, Rapid Nexus, a pioneering California-based med-tech company, has announced the receipt of FDA 510(k)...

Continue Reading
Grainger Approves Substantial Dividend to Shareholders

Updated Category News Views 131

Grainger's Commitment to Shareholders Through Dividends W.W. Grainger, Inc. (NYSE: GWW) has recently taken significant steps to reward its investors. The board of directors has officially approved a cash dividend of $2.26 per share. This strong move by Grainger underscores its commitment to providing long-term value to its shareholders. Details of the Dividend...

Continue Reading
Grupo Aeroportuario del Pacífico Secures New Credit Line Deal

Updated Category News Views 236

Grupo Aeroportuario del Pacífico Unveils Expanded Credit Line Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (PAC), a prominent player in the Mexican aviation sector, has recently announced a significant refinancing of its credit arrangements. The company has successfully secured a USD $40 million credit line from Banco Nacional de México, S.A. (Banamex). This...

Continue Reading